A research group from Japan employed artificial intelligence (AI) to develop next-generation stomach acid inhibitors. By producing AI designs and refining them in the laboratory, their findings ...

Cinclus Pharma is a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases -- Claret Capital Partners providing growth funding of up to ...

Nausea, heartburn, indigestion, upset stomach — anemia? Frequent sufferers of gastrointestinal symptoms may be doing more harm than good every time they reach for certain over-the-counter medications ...

The potential link between use of proton pump inhibitors and gastric cancer has been an ongoing controversial subject since the drugs entered the market in the late 1980s. Long-term use of proton pump ...

Dec. 17, 2003 — Esomeprazole is the most effective proton pump inhibitor (PPI) for gastric acid control, according to the results of a five-way crossover study published in the December issue of the ...

Gastroenterologist Saurabh Sethi recommends simple remedies for heartburn, acid reflux and digestive issues.

Prepyloric ulcers are a type of peptic or gastric ulcer. These open sores develop in the upper digestive tract, just above the pylorus, which is the opening to the small intestine. The tissues of the ...

Researchers at Nagoya University in Japan created and improved artificial intelligence (AI) designs to synthesize a candidate compound for a new gastric acid inhibitor with a better binding affinity ...

Claret Capital Partners invests €28M in Cinclus Pharma Cinclus Pharma is a late-stage clinical pharmaceutical company ...